Barclays PLC boosted its holdings in Organogenesis Holdings Inc. (NASDAQ:ORGO – Free Report) by 251.7% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange ...

Organogenesis had a negative return on equity ... cytokines, and growth factors; NuShield, dehydrated placental tissue covering amnion and chorion membranes for spongy/intermediate layer intact ...

PROVIDENCE — Rhode Island Commerce Corporation has granted Organogenesis, a Massachusetts biotech firm, more than $13 million in tax incentives, to support the company’s opening of a new ...

At close: January 3 at 4:00:01 PM EST ...

1 Day ORGO 1.27% DJIA -0.07% Russell 2K 0.11% Health Care/Life Sciences -0.90% ...

Organogenesis Holdings Inc. plans a bio-manufacturing facility at 100 Technology Way, a vacant building that once housed the now-defunct Rubius Therapeutics. The property in February 2023 was ...

(IRWD), and Organogenesis Holdings Inc. (ORGO), all trading below $5 ... Its products include Affinity, Novachor, Apligraf, Dermagraft, NuShield and more. On November 22, ORGO announced plans to ...

Build financial models with decades of earnings stats, ratios, and valuation data — all exportable — to power your trade ideas.

Nasdaq provides visual representation of analyst expected earnings growth. Read our earnings report guide before you consider the forecast information when making investment decisions. Visit the ...